Shirley Hopper
Impact in
- Computational Theory and Mathematics top 0.5%
- Computational Drug Discovery Methods
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Animal testing and alternatives 1
-
- Pharmacogenetics and Drug Metabolism 1
- Co-authors
- Joanna LatimerChristine J. McNameePhilippe SanséauMunir PirmohamedPatrick A. EyersAndrew J. DoigAlan NorrisDavid Cavalla
- Journals
- Nature Reviews Drug Discovery (1 paper)PubMed (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Shirley Hopper
2 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Computational Theory and Mathematics 889
- Infectious Diseases 515
- Molecular Biology 1.5k
- Pharmacology 149
- Molecular Medicine 72
Countries citing papers authored by Shirley Hopper
This map shows the geographic impact of Shirley Hopper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirley Hopper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirley Hopper more than expected).
Fields of papers citing papers by Shirley Hopper
This network shows the impact of papers produced by Shirley Hopper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirley Hopper. The network helps show where Shirley Hopper may publish in the future.
Co-authors
The 13 scholars most cited alongside Shirley Hopper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Drug repurposing: progress, challenges and recommendations Hit paper breakdown → | 2018 | 2940 |
| 2 | Building a solid GLP foundation: implementing shared training programs between the QAU and study personnel. | 1998 | 1 |
About Shirley Hopper
Shirley Hopper is a scholar working on Small Animals, Pharmacology, Computational Theory and Mathematics, Infectious Diseases and Physiology, having authored 2 papers that have together received 2.9k indexed citations. Recurring topics across this work include Animal testing and alternatives (1 paper), Tuberculosis Research and Epidemiology (1 paper), Computational Drug Discovery Methods (1 paper), Clinical Laboratory Practices and Quality Control (1 paper) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Computational Theory and Mathematics (889 citations), Infectious Diseases (515 citations), Molecular Biology (1.5k citations), Pharmacology (149 citations) and Molecular Medicine (72 citations). Shirley Hopper has collaborated with scholars based in United Kingdom. Frequent co-authors include Joanna Latimer, Christine J. McNamee, Philippe Sanséau, Munir Pirmohamed, Patrick A. Eyers, Andrew J. Doig, Alan Norris, David Cavalla, Katherine J. Escott and Tim Guilliams. Their work appears in journals such as Nature Reviews Drug Discovery and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.